SNWV SANUWAVE Health Inc

SANUWAVE Health to Attend the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) Conference

SANUWAVE Health to Attend the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) Conference

EDEN PRAIRIE, MN, April 27, 2023 (GLOBE NEWSWIRE) -- via – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce its participation in the upcoming 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) conference. The event will be co-located with the Diabetic Limb Salvage (DLS) conference from April 26-30, 2023 in National Harbor, MD.

The SAWC Spring | WHS conference is the premier event dedicated to the management, treatment, and prevention of wounds, and brings together leading wound care experts from around the world. The conference offers an opportunity for participants to share ideas and learn about the latest advancements in wound care technology.

"We are excited to attend the 2023 SAWC Spring | WHS conference and to participate in such an important event," said Tim Hendricks, Executive Vice President, Wound Care US of SANUWAVE Health. "This conference is an ideal platform for us to showcase our 6 Posters highlighting our innovative non-invasive, regenerative medicine solutions for the treatment of chronic wounds.”

  • South Korea - Application of extracorporeal shockwave therapy to improve microcirculation in diabetic foot ulcers - A prospective study -  Prof Dr Daun Jeong et al - funded by the South Korea Medical Device Development Fund grant - funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare
  • Brazil - Extracorporeal Shockwave (ESWT) APPLICATION IN COMPLEX CASES – Revascularization of Chronic LL Wounds Mixed Etiologies - Dr Cláudia Hidasy: Vascular & Endovascular Surgeon RIO DE JANEIRO -BRAZIL Hospital Quinta D´Or - Rede D'Or São Luiz
  • South Africa - - Brinsley David (RN) (B. Cur Nursing Degree) (Dip. UFS Wound Care) (Cert. IIWCC University of Toronto) Advanced Wound Care Practitioner, Cape Advanced Wound Care Centre, Netcare Christian Barnard Hospital, Cape Town, South Africa
  • Canada - - Dr Perry Mayer; Medical Director of The Mayer Institute (TMI), Center of Excellence Hamilton Ontario Canada
  • Canada - TRUE-Focused Acoustic Shockwave - Pulsed Acoustic Cellular Expression device: Effects on musculoskeletal tissue in treating Plantar Fasciitis in Patients with DFU - Brian Harper D.Ch. Clinical Director Newmarket Foot Centre, Ontario, Clinical Adjunct Professor Michener Institute at University Health Network Toronto New Market Ontario Canada
  • USA - - Anna Sanchez D.P.M, Director of San Antonio New Step Wound and Infusion Clinic San Antonio Texas USA

SANUWAVE Health is committed to advancing the field of regenerative medicine and improving patient care. The company's groundbreaking technology has been shown to accelerate the healing of chronic wounds, leading to improved patient outcomes and reduced healthcare costs.

"We are proud to be at the forefront of regenerative medicine and to have the opportunity to share our innovative solutions with other leaders in the field," said Hendricks. "We look forward to continuing to collaborate with other attendees to advance the science and improve patient care."

About SANUWAVE

SANUWAVE Health is a leading medical technology company focused on the development and commercialization of non-invasive, regenerative medicine solutions for a range of medical conditions, including wound healing. The company's innovative technology has been shown to accelerate the healing of chronic wounds, leading to improved patient outcomes and reduced healthcare costs. SANUWAVE Health is committed to advancing the field of regenerative medicine and improving patient care.

For more information, visit .

CONTACT

Kevin Richardson, II

Chief Executive Officer





EN
27/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SANUWAVE Health Inc

 PRESS RELEASE

Sanuwave Health to Uplist to the Nasdaq Global Market

Sanuwave Health to Uplist to the Nasdaq Global Market Trading Under the Ticker “SNWV” Expected to Begin on March 7, 2025 EDEN PRAIRIE, Minn., March 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the “Company” or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, announced today that its common stock has been approved for listing on the Nasdaq Global Market (“Nasdaq”). Trading on Nasdaq is expected to commence at the market open on March 7, 2025, with shares continuing to trade under the ticker symbol “SNWV.” The Company’s shares will...

 PRESS RELEASE

SANUWAVE Health to Participate in 37th Annual Roth Conference

SANUWAVE Health to Participate in 37th Annual Roth Conference EDEN PRAIRIE, Minn., Feb. 19, 2025 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that Morgan Frank, Chief Executive Officer, will participate in the 37th Annual Roth Conference to be held on March 16-18 at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California. Management will be available for one-on-one meetings throughout the conference. Interested investors should contact their Roth representative or email to sched...

 PRESS RELEASE

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Resu...

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results Q3 2024 revenues were $9.4 million, up 89% from Q3 2023. This was an all-time quarterly record for the Company. Q3 2024 gross margin was 75.5%, vs 71.5% in Q3 2023 GAAP Operating Income was $2.0 million Company provides guidance for revenue growth of 40-50% for Q4 2024 versus Q4 2023 EDEN PRAIRIE, Minn., Nov. 08, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to provide its financial ...

 PRESS RELEASE

SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (E...

SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results EDEN PRAIRIE, Minn., Nov. 04, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, November 8, 2024, at 8:30 AM (ET) to present its Q3 2024 financial results. Telephone access to the call will be available by dialing the following numbers: Participant Dial-in Information Toll Free: 1-800-267-6316 Toll/International: 1-203-518-97...

 PRESS RELEASE

SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and...

SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering 1-for-375 reverse stock split effective at market open today Exchanged $43.2 million in principal amount of convertible notes and warrants previously exercisable for approximately 1.7 billion pre-split shares for approximately 4.0 million post-split shares Closed $10.3 million equity only PIPE offering at $8.25 per share of common stock led by certain institutional investors, including AWM Investment Company, Inc., the investment adviser of the Special Situations Funds and with participation from Ma...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch